Transfection Technologies Market Is Projected To Top A Valuation Of US$ 2.27 Billion By 2033

According to a recent market research and competitive intelligence report by Fact.MR, the global transfection technologies market is expected to grow from its current value of US$ 1.10 billion to US$ 2.27 billion by the end of 2033.

Transfection technique is used to insert nucleic acids, such as ribonucleic acid (RNA), deoxyribonucleic acid (DNA), and oligonucleotides, into cells. It is delivered using a variety of chemical, physical, and biological approaches that have the ability to alter some cell properties. Co-transfection, cationic lipid transfection, electroporation, and in-vivo transfection are among the methods. This strategy is frequently employed in genomic studies including gene expression, screening, RNA interference, in vivo research, and the bioproduction of viruses and proteins.

Download Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8216?AS

Key Pioneers

• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche AG
• Life Technologies Corporation
• Lonza Group AG
• MilliporeSigma
• PolyPlus Battery Company (PPBC)
• Promega Corporation
• Qiagen NV
• SignaGen Laboratories
• Thermo Fisher Scientific, Inc.

Market Developments

• Thermo Fisher Scientific, a US-based corporation well known for its reagent and other equipment supplies, completed the acquisition of Pharmaceutical Product Development (PPD), a US-based CRO, on April 15, 2021. PPD received a settlement of US$ 17.4 billion. Thermo Fisher’s clinical research portfolio is strengthened by the acquisition.
• April 9, 2020: The company “Celsee” was successfully acquired by California-based “Bio-Rad Laboratories”, which creates specialised technology for life science. A US-based firm “Celsee” specialises in transfection technologies. Although the financial details of the agreement were kept private, Bio-Rad said that it would benefit the company’s single-cell analytic capabilities.
• Easy introduction of DNA, RNA, siRNA, or oligonucleotides into eukaryotic cells can be accomplished quickly, simply, and repeatedly via cationic lipid transfection technologies. It permits the highly effective transfection of various cell types, such as adherent, suspension, insect, and primary cultures. Thermo Fisher Scientific, Inc. has a wider portfolio range of cationic-lipid transfection reagents.
• February 3, 2022: To increase their proficiency in the design and production of unique DNA vectors, Polypus, a supplier of transfection reagents, bought e-Zyvec, a company based in France.
• For instance, in March 2019, Lonza introduced CellBio Services, a broad spectrum of distinctive services tailored to the needs of research applications. These include cell-line expansion, transfection, and cell banking services.

Key Statistics Supporting the Surge

• Global demand for transfection technologies is expected to increase at a CAGR of 7.5% from 2023 to 2033.
• China’s market is predicted to expand at a CAGR of 7% during the projected period.
• Worldwide sales of therapeutic delivery technologies are expected to rise at a CAGR of 8% during the forecast period.
• Demand for protein production systems is predicted to expand at a CAGR of 7.5% during the next 10 years.

 Industry Research

• By Application :
  • Protein Production
  • Therapeutic Delivery
    • Biotherapeutics
    • Electro-chemotherapy and Electro-immunotherapy
  • Bio-medical Research
    • Cancer Research
    • Transgenic Models
    • Gene and Protein Expression Studies
    • Cell-based Microarrays for Drug Discovery and Development
• By Method :
  • Reagent-based Method
    • Lipid Mediated Transfection (Lipofection)
    • Calcium Phosphate
    • DEAE-dextran
    • Catonic Polymers
    • Activated Dendrimers
    • Magnetic Beads
  • Instrument-based Method
    • Electroporation
    • Microinjection
    • Laserfection
    • Biolistic technology
  • Virus-based Method
• By Technology :
  • Physical Transfection
  • Biochemical-based Transfection
  • Viral-vector-based Transfection
• By End User :
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Academic & Research Institutes
  • Hospitals
• By Region :
  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • MEA

Get Access of Complete Report:
https://www.factmr.com/checkout/8216

Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Email : sales@factmr.com